Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to determine how well patients with gastric or
gastroesophageal junction adenocarcinoma respond to chemotherapy with epirubicin, cisplatin
and 5-fluorouracil followed by continuous infusion 5-fluorouracil chemotherapy given along
with radiation therapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital